Published 2010
| Version v1.0.0
Journal Article
Open
Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia
Creators
Abstract
Serious bleeding and thrombotic complications are frequent in acute promyelocytic leukemia (APL) and are major causes of morbidity and mortality. Microparticles (MP) have been used to study the risk and pathogenesis of thrombosis in many malignant disorders. To date, from published articles, this approach had not been applied to APL. In this article, the hemostatic dysfunction in this disorder is briefly reviewed. A study design to address this problem using MP is described. MP bearing tissue factor, profibrinolytic factors (tissue plasminogen activator and annexin A2), and the antifi-brinolytic factor plasminogen activator inhibitor type 1 were measured using flow cytometry. The cellular origin of the MP was identified by specific cell surface markers. Comparison of the various populations of MP was made between samples collected at the time of diagnosis with those collected at molecular remission. Preliminary data suggest that this approach is feasible.Other
original_citation: Kwaan, H. C., & Rego, E. M. (2010). Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia. Semin Thromb Hemost, 36(8), 917-924. doi:10.1055/s-0030-1267045Files
MP_APL_kwaan_rego.pdf
Files
(135.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ef4f5521303066f77b1d0c57b8f56b0b
|
135.3 kB | Preview Download |
Additional details
Identifiers
- ARK
- ark:/c8131/g3dp4z
Dates
- Created
-
2010When the item was originally created.